BRIEF-Inovio pharmaceuticals says DMAB antibody and DNA vaccine targeting chikungunya virus provided 100 pct protection against a lethal virus challenge in mice
* "DNA vaccine and DMAB products show potential, separately and in combination, to offer immediate and long term protection"
No comments:
Post a Comment